The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men
The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men
复制标题
DOI:
10.1210/jc.2003-031069
复制
发表时间:
2004-07-01
影响因子:
5.8
通讯作者:
Jones, TH
中科院分区:
文献类型:
--
作者:
Malkin, CJ;Pugh, PJ;Jones, TH
Testosterone has immune-modulating properties, and current in vitro evidence suggest that testosterone may suppress the expression of the proinflammatory cytokines TNFalpha, IL-1beta, and IL-6 and potentiate the expression of the antiinflammatory cytokine IL-10. We report a randomized, single-blind, placebo-controlled, crossover study of testosterone replacement (Sustanon 100) vs. placebo in 27 men (age, 62+/-9 yr) with symptomatic androgen deficiency (total testosterone, 4.4+/-1.2 nmol/liter; bioavailable testosterone, 2.4+/-1.1 nmol/liter). Compared with placebo, testosterone induced reductions in TNFalpha (-3.1+/-8.3 vs. 1.3+/-5.2 pg/ml; P=0.01) and IL-1beta(-0.14+/-0.32 vs. 0.18+/-0.55 pg/ml; P=0.08) and an increase in IL-10 (0.33+/-1.8 vs. -1.1+/-3.0 pg/ml; P=0.01); the reductions of TNFalpha and IL-1beta were positively correlated (r(S)=0.588; P=0.003). In addition, a significant reduction in total cholesterol was recorded with testosterone therapy (-0.25+/-0.4 vs. -0.004+/-0.4 mmol/liter; P=0.04). In conclusion, testosterone replacement shifts the cytokine balance to a state of reduce inflammation and lowers total cholesterol. Twenty of these men had established coronary disease, and because total cholesterol is a cardiovascular risk factor, and proinflammatory cytokines mediate the development and complications associated with atheromatous plaque, these properties may have particular relevance in men with overt vascular disease.